Plasma-activated saline solutions and method of making plasma activated saline solutions
A method for manufacturing plasma-activated saline for treatment of cancer cells. The method comprises the steps of immersing a cathode in saline solution in a container, positioning an anode at a fixed distance from a surface of said saline solution in said container and applying electrical energy to said anode for a fixed period of time, wherein said fixed distance and said fixed period of time are selected to cause a plasma self-organized pattern at a surface of said saline solution with an atmospheric discharge between said anode and said cathode.
1. A method for manufacturing plasma-activated saline for treatment of cancer cells comprising:
immersing a cathode in saline solution in a container;
positioning an anode at a fixed distance from a surface of said saline solution in said container; and
applying electrical energy to said anode for a fixed period of time;
wherein said fixed distance and said fixed period of time are selected to cause a plasma self-organized pattern at a surface of said saline solution with an atmospheric discharge between said anode and said cathode and
where in said plasma self-organized pattern comprises a double ring structure.
2. The method for manufacturing plasma-activated saline for treatment of cancer cells according to claim 1 wherein said fixed distance is 4-6 mm.
3. The method for manufacturing plasma-activated saline for treatment of cancer cells according to claim 1 wherein said fixed time is 40 seconds.
4. The method for manufacturing plasma-activated saline for treatment of cancer cells according to claim 1 wherein said double ring structure comprises a solid inner ring surrounded by a continuous outer ring.
5. The method for manufacturing plasma-activated saline for treatment of cancer cells according to claim 1 wherein said double ring structure comprises a solid inner ring surrounded by a discontinuous outer ring.
6. The method for manufacturing plasma-activated saline for treatment of cancer cells according to claim 1 wherein said double ring structure comprises a continuous inner ring surrounded by a continuous outer ring.
7. The method for manufacturing plasma-activated saline for treatment of cancer cells according to claim 1 wherein said double ring structure comprises a continuous inner ring surrounded by a discontinuous outer ring.